US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Johnson & Johnson
< Previous
1
2
3
4
5
Next >
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
October 01, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
September 10, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
September 02, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
August 31, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
August 10, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference
August 04, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
August 04, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
July 29, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
July 29, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
July 27, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
July 22, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award
July 16, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026
July 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
July 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform
July 08, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
June 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL, an Advanced Lens Option for Cataract Surgeons and Patients
June 11, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform
June 08, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
May 27, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
May 12, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 11, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
May 05, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
April 30, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
April 27, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
April 21, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
April 21, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
April 15, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
April 14, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
April 14, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
April 10, 2026
From
Johnson & Johnson
Via
Business Wire
Tickers
JNJ
< Previous
1
2
3
4
5
Next >
